|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Pancreatic Cancer Research Team |
|---|---|
| Information provided by (Responsible Party): | Pancreatic Cancer Research Team |
| ClinicalTrials.gov Identifier: | NCT00296114 |
Purpose
To prospectively collect serum and DNA samples from subjects with pancreatic cancer, pancreatitis, liver disease, and from healthy and at-risk volunteers in order to identify novel biomarkers for early diagnosis, differential diagnosis, stage, natural history of the disease, response to treatment, and to identify novel targets for therapeutic interventions. In particular:
| Condition | Intervention |
|---|---|
|
Pancreas Cancer |
Procedure: Serum and DNA Samples |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Pancreatic Cancer Serum and DNA Repository |
Whole Blood and Serum Samples
| Enrollment: | 690 |
| Study Start Date: | February 2004 |
| Study Completion Date: | December 2011 |
| Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Samples are collected on: Pancreatic Cancer, Liver Disease, Pancreatitis, Healthy and Healthy at Risk Subjects.
Inclusion Criteria:
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
4.1 At the time of subject registration, CRAB will verify the institution's IRB date to ensure that the subject can be enrolled.
4.2 Potential study participants must meet the eligibility criteria found in Section 12.0 (Eligibility Checklist). Candidates will fall into one of four groups:
Eligibility Checklist:
Contacts and Locations| United States, Arizona | |
| Scottsdale Healthcare | |
| Scottsdale, Arizona, United States, 85259 | |
| University of Arizona/Arizona Cancer Center | |
| Tucson, Arizona, United States, 85724 | |
| United States, California | |
| UCLA Medical Center | |
| Los Angeles, California, United States, 90024-6970 | |
| United States, Illinois | |
| RUSH University Medical Center | |
| Chicago, Illinois, United States, 60612 | |
| United States, Maryland | |
| Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins | |
| Baltimore, Maryland, United States, 21231 | |
| United States, Minnesota | |
| Abbott Northwestern Hospital/Virginia Piper Cancer Institute | |
| Minneapolis, Minnesota, United States, 55407 | |
| United States, New Mexico | |
| University of New Mexico | |
| Albuquerque, New Mexico, United States, 87131 | |
| United States, Tennessee | |
| Sarah Cannon Research Institute | |
| Nashville, Tennessee, United States, 37203 | |
| United States, Texas | |
| South Texas Oncology and Hematology | |
| San Antonio, Texas, United States, 78229 | |
| Spain | |
| University Hospital (12 De Octubre) | |
| Madrid, Spain | |
| Study Chair: | Manuel Hidalgo, MD, PhD | Hospital Universitario Sanchinarro, Madrid, Spain |
More Information
| Responsible Party: | Pancreatic Cancer Research Team |
| ClinicalTrials.gov Identifier: | NCT00296114 History of Changes |
| Obsolete Identifiers: | NCT00250107 |
| Other Study ID Numbers: | PCRT 03 001 |
| Study First Received: | February 22, 2006 |
| Last Updated: | December 8, 2011 |
| Health Authority: | United States: Institutional Review Board |
|
Cancer Pancreas |
|
Pancreatic Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms |
Endocrine Gland Neoplasms Digestive System Diseases Pancreatic Diseases Endocrine System Diseases |